EXPLORE MINDSIGNS SOLUTIONS
We develop clinically validated AI technologies for brain monitoring and neuropsychiatric assessment. Our platform combines two intelligents analytics engines, NeuroBrowser™ and GenMind™. Together, they power a new standard of precision in diagnosing and managing brain conditions.
CLINICAL APPLICATIONS
Transforming Care Across Conditions
Current Focus
Platform: Concussion
Rapid, point-of-care detection of brain slowing and recovery patterns. We enable early return-to-play and safe return-to-work decisions.
Lead Program 1
AI-assisted seizure, spike and slowing detection for faster and more accurate review. We reduce diagnostic time and improve inter-rater reliability.
Lead Program 2
Quantification of cognitive and negative symptoms through biomarkers. We support patient monitoring and precision psychiatry at scale.
Next Program
Platform: Bipolar Disorder
Continuous neural monitoring to detect shifts in brain activity and mood states. We facilitate early intervention and personalized treatment.
Impact That Matters
1 in 5
people live with a neurological or psychiatric disorder
$2 trillion
annual global costs of untreated brain and mental health conditions
1,000+
patients already supported by Mindsigns' AI brain analytics
